Compare AXSM & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXSM | RHI |
|---|---|---|
| Founded | 2012 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 3.3B |
| IPO Year | 2015 | N/A |
| Metric | AXSM | RHI |
|---|---|---|
| Price | $148.16 | $27.59 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 20 | 7 |
| Target Price | ★ $176.00 | $40.00 |
| AVG Volume (30 Days) | 519.5K | ★ 2.0M |
| Earning Date | 11-03-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 8.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.54 |
| Revenue | $561,263,000.00 | ★ $5,458,499,000.00 |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | $1.14 |
| P/E Ratio | ★ N/A | $17.95 |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $25.22 |
| 52 Week High | $152.94 | $78.41 |
| Indicator | AXSM | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 50.93 |
| Support Level | $144.00 | $26.32 |
| Resistance Level | $150.00 | $28.01 |
| Average True Range (ATR) | 4.15 | 0.80 |
| MACD | -0.73 | 0.22 |
| Stochastic Oscillator | 57.42 | 67.59 |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.